Regulations on the Use of Antibiotics in Livestock Production in South America: A Comparative Literature Analysis

Author:

Da Silva Rafael Almeida1ORCID,Arenas Nelson Enrique2ORCID,Luiza Vera Lucia1,Bermudez Jorge Antonio Zepeda1,Clarke Sian E.3

Affiliation:

1. Pharmaceutical Assistance Department, Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro 21040-361, Brazil

2. Faculty of Sciences, Universidad Antonio Nariño, Bogotá 110231, Colombia

3. Disease Control Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK

Abstract

As a global health problem, antimicrobial resistance (AMR) crosses national borders, leading UN (United Nations) multilateral agencies to call for all countries to improve the stewardship of antibiotics in humans and animals. South American countries have changed their regulations regarding antibiotic use in livestock production. This literature review examines how far the five largest meat-producing countries in South America (Argentina, Brazil, Chile, Colombia, and Uruguay) have come in terms of the relevant legislation. Rules on market entry (marketing authorization and official distribution systems) are already set in all countries examined. Four countries do not allow growth promoters based on critically important antibiotics, and countries have also begun to set guidelines and minimum welfare and biosecurity requirements to reduce the therapeutic demand for antibiotics. Nonetheless, there are aspects related to the distribution, use, and disposal of antibiotics that need to be developed further. In conclusion, legislation in South American countries is moving towards the goals set by UN multilateral agencies, but more can be done. Differences between countries’ rules and the gold standards set by the World Organization for Animal Health (OIE), World Health Organization (WHO), and Food and Agriculture Organization of the United Nations (FAO) reveal possible adaptations to the countries’ realities. Further studies must examine compliance with the legislation already set and investigate other tools that can be used alongside legislation as a driving force to change stakeholder behaviour.

Funder

Coordination for the Improvement of Higher Education Personnel

National Council for Scientific and Technological Development

United Kingdom Research and Innovation (UKRI)-Global Challenges Research Fund

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology

Reference140 articles.

1. World Health Organization (2019). No Time to Wait: Securing the Future from Drug-Resistant Infections, World Health Organization. Available online: https://www.who.int/publications/i/item/no-time-to-wait-securing-the-future-from-drug-resistant-infections.

2. Munita, J.M., and Arias, C.A. (2016). Virulence Mechanisms of Bacterial Pathogens, ASM Press. [5th ed.].

3. Silva, R.A. (2019). A Resistência a Antimicrobianos: Revisão Sobre o Uso de Antibióticos Em Animais e a Resistência Em Humanos. [Master’s Thesis, Escola Nacional de Saúde Pública Sérgio Arouca—Fiocruz]. Available online: https://www.arca.fiocruz.br/handle/icict/48756.

4. Resistência a Antimicrobianos: A Formulação da Resposta No Âmbito da Saúde Global;Oliveira;Saúde Em Debate,2020

5. Centers for Disease Control and Prevention (2021, October 03). One Health, Available online: https://www.cdc.gov/onehealth/basics/history/.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3